These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 8376616

  • 1. Predictors of valproate response in bipolar rapid cycling.
    Calabrese JR, Woyshville MJ, Kimmel SE, Rapport DJ.
    J Clin Psychopharmacol; 1993 Aug; 13(4):280-3. PubMed ID: 8376616
    [Abstract] [Full Text] [Related]

  • 2. Rapid cycling bipolar disorder and its treatment with valproate.
    Calabrese JR, Rapport DJ, Kimmel SE, Reece B, Woyshville MJ.
    Can J Psychiatry; 1993 Apr; 38(3 Suppl 2):S57-61. PubMed ID: 8500080
    [Abstract] [Full Text] [Related]

  • 3. A medication algorithm for treatment of bipolar rapid cycling?
    Calabrese JR, Woyshville MJ.
    J Clin Psychiatry; 1995 Apr; 56 Suppl 3():11-8. PubMed ID: 7883737
    [Abstract] [Full Text] [Related]

  • 4. [Brief history of the development of valproate in bipolar disorders].
    Lempérière T.
    Encephale; 2001 Apr; 27(4):365-72. PubMed ID: 11686059
    [Abstract] [Full Text] [Related]

  • 5. Spectrum of efficacy of valproate in 78 rapid-cycling bipolar patients.
    Calabrese JR, Markovitz PJ, Kimmel SE, Wagner SC.
    J Clin Psychopharmacol; 1992 Feb; 12(1 Suppl):53S-56S. PubMed ID: 1541718
    [Abstract] [Full Text] [Related]

  • 6. Valproate in the treatment of rapid-cycling bipolar disorder.
    McElroy SL, Keck PE, Pope HG, Hudson JI.
    J Clin Psychopharmacol; 1988 Aug; 8(4):275-9. PubMed ID: 3145291
    [Abstract] [Full Text] [Related]

  • 7. Rational polypharmacy in the bipolar affective disorders.
    Post RM, Ketter TA, Pazzaglia PJ, Denicoff K, George MS, Callahan A, Leverich G, Frye M.
    Epilepsy Res Suppl; 1996 Aug; 11():153-80. PubMed ID: 9294735
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of quetiapine monotherapy in rapid-cycling bipolar disorder in comparison with sodium valproate.
    Langosch JM, Drieling T, Biedermann NC, Born C, Sasse J, Bauer H, Walden J, Bauer M, Grunze H.
    J Clin Psychopharmacol; 2008 Oct; 28(5):555-60. PubMed ID: 18794653
    [Abstract] [Full Text] [Related]

  • 9. [Predictors of prophylactic response to lithium].
    Rohayem J, Baylé JF, Richa S.
    Encephale; 2008 Sep; 34(4):394-9. PubMed ID: 18922242
    [Abstract] [Full Text] [Related]

  • 10. A 12-week, open, randomized trial comparing sodium valproate to lithium in patients with bipolar I disorder suffering from a manic episode.
    Bowden C, Göğüş A, Grunze H, Häggström L, Rybakowski J, Vieta E.
    Int Clin Psychopharmacol; 2008 Sep; 23(5):254-62. PubMed ID: 18703934
    [Abstract] [Full Text] [Related]

  • 11. Health-economic implications of the onset of action of antimanic agents.
    Keck PE, McElroy SL, Bennett JA.
    J Clin Psychiatry; 1996 Sep; 57 Suppl 13():13-8; discussion 19-22. PubMed ID: 8970501
    [Abstract] [Full Text] [Related]

  • 12. The manic syndrome: factors which may predict a patient's response to lithium, carbamazepine and valproate.
    Dilsaver SC, Swann AC, Shoaib AM, Bowers TC.
    J Psychiatry Neurosci; 1993 Mar; 18(2):61-6. PubMed ID: 8461283
    [Abstract] [Full Text] [Related]

  • 13. Functional outcomes in first-episode patients with bipolar disorder: a prospective study from the Systematic Treatment Optimization Program for Early Mania project.
    Kauer-Sant'Anna M, Bond DJ, Lam RW, Yatham LN.
    Compr Psychiatry; 2009 Mar; 50(1):1-8. PubMed ID: 19059506
    [Abstract] [Full Text] [Related]

  • 14. Mood stabilizer augmentation in apparently "unipolar" MDD: predictors of response in the naturalistic French national EPIDEP study.
    Hantouche EG, Akiskal HS, Lancrenon S, Chatenêt-Duchêne L.
    J Affect Disord; 2005 Feb; 84(2-3):243-9. PubMed ID: 15708422
    [Abstract] [Full Text] [Related]

  • 15. [Valproate in the treatment of bipolar disorder].
    Rzewuska M.
    Psychiatr Pol; 2002 Feb; 36(2):239-57. PubMed ID: 12043042
    [Abstract] [Full Text] [Related]

  • 16. Divalproex in the treatment of bipolar disorder.
    Keck PE, McElroy SL.
    Psychopharmacol Bull; 2003 Feb; 37 Suppl 2():67-73. PubMed ID: 15021862
    [Abstract] [Full Text] [Related]

  • 17. Brain oscillatory responses in patients with bipolar disorder manic episode before and after valproate treatment.
    Ozerdem A, Güntekin B, Tunca Z, Başar E.
    Brain Res; 2008 Oct 15; 1235():98-108. PubMed ID: 18644356
    [Abstract] [Full Text] [Related]

  • 18. [Prediction of treatment response in acute mania: controlled clinical trials with divalproex].
    Swann AC.
    Encephale; 2001 Oct 15; 27(3):277-9. PubMed ID: 11488258
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study.
    Salloum IM, Cornelius JR, Daley DC, Kirisci L, Himmelhoch JM, Thase ME.
    Arch Gen Psychiatry; 2005 Jan 15; 62(1):37-45. PubMed ID: 15630071
    [Abstract] [Full Text] [Related]

  • 20. A pharmacoeconomic model of divalproex vs. lithium in the acute and prophylactic treatment of bipolar I disorder.
    Keck PE, Nabulsi AA, Taylor JL, Henke CJ, Chmiel JJ, Stanton SP, Bennett JA.
    J Clin Psychiatry; 1996 May 15; 57(5):213-22. PubMed ID: 8626353
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.